Premium
Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging
Author(s) -
Szczepaniak Lidia S.,
Dobbins Robert L.,
Metzger Gregory J.,
SartoniD'Ambrosia Greta,
Arbique Debbie,
Vongpatanasin Wanpen,
Unger Roger,
Victor Ronald G.
Publication year - 2003
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.10372
Subject(s) - triglyceride , in vivo , medicine , ex vivo , cardiology , cardiac function curve , steatosis , endocrinology , cholesterol , chemistry , biology , heart failure , microbiology and biotechnology
Recent experimental data suggest that adiposity directly damages the heart by promoting ectopic deposition of triglyceride, a process known as myocardial steatosis. The goal of this study was to develop and validate proton magnetic resonance spectroscopy ( 1 H MRS) as an in vivo tool to measure myocardial lipid content. Complementary studies in rat tissue ex vivo and in 15 healthy humans in vivo provided evidence that 1 H MRS constitutes a reproducible technique for the measurement of myocardial triglyceride. In myocardial tissue from Zucker rats, the 1 H MRS measurement of triglyceride matched that obtained by biochemical measurement ( P < 0.001). In human subjects triglyceride was evident in the hearts of even the very lean individuals and was elevated in overweight and obese subjects. Increased myocardial triglyceride content was accompanied by elevated LV mass and suppressed septal wall thickening as measured by cardiac imaging. Magn Reson Med 49:417–423, 2003. © 2003 Wiley‐Liss, Inc.